1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow brca2 Mutation Carrier: new trials by email Literature Review of brca2 Mutation Carrier trials Research Report on brca2 Mutation Carrier
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease therapeutic estradiol, deslorelin, therapeutic testosterone - brca1 Mutation Carrier, brca2 Mutation Carrier | Phase 2 | Unknown | City of Hope Medical Center | 11 | 2004-03-11 | 2024-08-28 |
Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Estradiol (1) · Testosterone Propionate (1) · Watchful Waiting (1) · deslorelin (1)
City of Hope Medical Center (1)
United States (1)
P30CA033572 (1)